EPCAM and cancer: Theapproach is based on immunomagnetic separation (IMS) of the exosomesusing CD326 cancer-related biomarker, followed by amplification bydouble-tagging reverse transcription PCR of the GAPDH transcriptson poly(dT)-MPs.